252 results
Page 3 of 13
8-K
EX-99.1
lzo4sqebmq1jz
16 May 22
Adamis Pharmaceuticals Reports First Quarter 2022 Financial Results and Provides Corporate Update
4:44pm
8-K
EX-99.1
yxon0dz0g 50
31 Mar 22
Adamis Pharmaceuticals Reports Full Year 2021 Financial Results and Provides Corporate Update
5:02pm
8-K
EX-14.1
ulz3ihgp5rxjy25s6
18 Feb 22
Amendments to the Registrant's Code of Ethics, or Waiver of a Provision of the Code of Ethics
4:43pm
8-K
EX-99.1
lp6yig50
10 Jan 22
Adamis Pharmaceuticals Submits Fast Track Application to FDA for Tempol for the Treatment and Prevention of COVID-19
4:31pm
8-K
wbqxkbkyqgziqg4zdin
10 Jan 22
Adamis Pharmaceuticals Submits Fast Track Application to FDA for Tempol for the Treatment and Prevention of COVID-19
4:31pm
8-K
EX-99.1
52aah
22 Nov 21
Adamis Pharmaceuticals Announces Third Quarter 2021 Financial Results and Provides Corporate Update
5:00pm
8-K
EX-99.1
9pegc tvya
18 Oct 21
Adamis Receives FDA Approval for ZIMHI
4:41pm
8-K
EX-99.1
eu759
24 Aug 21
Adamis Announces Appointment of David C. Benedicto as Chief Financial Officer and Other Events
5:06pm
DEFA14A
luibs66a6hwn p0
13 Jul 21
Additional proxy soliciting materials
8:27am
DEFA14A
p8ajk
13 Jul 21
Additional proxy soliciting materials
6:04am
8-K
EX-99.1
0dhjwi1pb9 qcucc8baq
13 Jul 21
Investor Presentation July 2021
6:02am
DEFA14A
xhfdhggqv6oy
1 Jul 21
Additional proxy soliciting materials
8:20am
DEFA14A
iy9sybttyw87anmz
28 Jun 21
Additional proxy soliciting materials
7:31am
DEFA14A
sa4yl61ryebg6p4o2
14 Jun 21
Additional proxy soliciting materials
10:32am
8-K
EX-99.1
whi4c xylg8xrk
15 Apr 21
Adamis Pharmaceuticals Announces 2020 Financial Results and Business Update
5:03pm